Cipla | CIPLA - Sales Revenues

Stock Price
1,426.30
Daily Change
-5.80 -0.40%
Monthly
16.01%
Yearly
-4.38%
Q2 Forecast
1,401.45

Cipla reported INR65.41B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Bio Path 0 0 Mar/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Minerva Neurosciences USD 0 0 Sep/2024
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
TherapeuticsMD USD 234K 79K Jun/2024
UPL INR 183.35B 59.74B Mar/2026